Pharmacokinetics of cefotaxime in neonatal pony foals.

The research article discusses a study performed on the pharmacokinetics or how the body processes cefotaxime, an antibiotic, in neonatal pony foals. The aim was to understand the drug’s disposition in the body to further optimize its dosage for treating neonatal sepsis and meningitis in ponies.

Research Methodology

• The researchers administered a single intravenous (IV) dose of cefotaxime to 1-week-old pony foals.
• The serum concentrations of cefotaxime and its metabolite, desacetylcefotaxime, were then monitored and measured.

Drug Disposition Data

• The data obtained on cefotaxime comportment in the pony’s body was found to conform to a two-compartment model with an elimination half-life of 0.60 hours.
• Elimination half-life refers to the time it takes for the drug concentration in the body to decrease by half. Therefore, in about 0.6 hours, half the initial dose of cefotaxime administered would be removed from the pony’s body.
• The combined data on both the original drug, cefotaxime, and its metabolite, desacetylcefotaxime, fit a more complex four-compartment model. This indicates that both substances are distributed throughout the body and undergo several processes before being fully eliminated.

Dosing Recommendations

• Based on these findings, the researchers recommended a dosage of 40 mg of cefotaxime per kg of body weight. The frequency was suggested to be every 4 to 6 hours for neonatal foals with gram-negative septicemia while it was set to every 2 hours for foals with meningitis.
• The researchers have made these recommendations based on the aim to maintain an effective drug concentration in the body throughout the treatment duration. However, these suggested dosages require further analysis and study before they can be employed clinically.